Biomarker Testing

Translational Biomarker Platforms from Discovery to Clinical Validation

Contact Us

icon library-1-1

Immunoassays

  • Single and Multiplex Assays

  • 650+ analytes 

  • Browse Off-The-Shelf Research Panels

  • Explore Panels by Indication

  • Immunoassays for Animal Models

  • Custom Panel Development/Luminex

  • Custom ELISAs

Explore
ChatGPT Image Feb 17, 2026, 11_53_45 AM

In-House Biomarker Platforms

  • Alinity ci-series
  • Attune NxT
  • CLARIOStar
  • Ella
  • Isolight
  • Jess
  • Luminex 200
  • MSD
  • Peggy Sue
  • SMCxPRO
  • QuantStudio 6 Pro
  • WES
Explore
icon library-2

CLIA Certified Lab

Through our sister company SBH Diagnostics we provide: 

  • CLIA-certified clinical biomarker testing
  • GLP-compliant laboratory operations
  • Clinical trial sample processing
  • Chain-of-custody and regulatory documentation
  • Sample accessioning, storage, and biobanking
  • PK/PD biomarker analysis
  • Custom clinical biomarker panels
  • Flexible sample types: whole blood, serum, plasma, urine, tissue, PBMCs, CSF, cell culture supernatants
Explore
Explore Biomarker Panels by Indication
ChatGPT Image Mar 4, 2026, 10_49_00 AM
Bringing You To Your Next Milestone

Biomarkers drive smarter drug development. They reduce uncertainty, de-risk clinical programs, and accelerate timelines by providing quantitative insight into disease biology, target engagement, pharmacodynamics, and patient response. A well-designed biomarker strategy can determine whether a program advances — or fails — early enough to save years of development time and millions in cost.

28 Years of Biomarker Expertise and Clinical Sample Processing